Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating a mobile app for treating chronic insomnia

Official title: Determination of Optimal Sleep Treatment Elements (The DOSE Project) - DISA RCT

Run by Aarhus University Hospital · NCT06781203 · Data updated 2026-11-12

This study is testing a mobile app that offers therapy for chronic insomnia to see if it can help people sleep better without using medication.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorAarhus University Hospital
Academic / other
Locations1 site (Aarhus)
StatusRecruiting
StartedDecember 17, 2024
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedJanuary 17, 2025
Trial IDNCT06781203 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who report moderate-to-severe insomnia symptoms and have access to a smartphone.

Probably not a fit

Patients with mild or no clinically relevant insomnia symptoms, severe comorbidities affecting sleep, or those currently receiving similar therapies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the feasibility, acceptability, and effectiveness of a fully automated mobile application delivering cognitive behavioral therapy for insomnia (eCBTI) in a general practice setting. It addresses the widespread issue of insomnia, which affects a significant portion of the population and is often treated with potentially harmful medications. The study will also explore the impact of eCBTI on psychological and physical comorbidities, as well as its cost-effectiveness. By integrating eCBTI into general practice, the study seeks to provide a non-pharmacological alternative to traditional treatments.

Why it matters

Potential benefit: If successful, this approach could provide an accessible and effective treatment option for patients suffering from chronic insomnia without the risks associated with medication.

How similar studies have gone: Previous studies have shown that digitally delivered CBTI is effective, but this specific integration into general practice is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥18 years)
* Individuals who report moderate-to-severe insomnia symptoms (a score ≥10 on the Insomnia Severity Index, ISI)
* Individuals referred by their general practitioner
* Individuals with access to a smartphone with internet connection
* Individuals who report sufficient technological proficiency (e.g., ability to download apps)

Exclusion Criteria:

* Children (\<18 years)
* Individuals who report mild or no clinically relevant insomnia symptoms (a score \<10 on the ISI)
* Individuals who have a shift-work schedule or are on maternity/paternity leave
* Individuals who are unable to read Danish
* Individuals who report severe physical or psychological comorbidity with known effects on sleep (e.g., psychosis, cancer, COPD)
* Individuals who report other diagnosed sleep or circadian rhythm disorders (e.g., sleep apnea, narcolepsy)
* Individuals who are currently receiving or have recently received CBTI or eCBTI

Where it's running

  • Aarhus University Hospital
    Aarhus, Denmark
    Recruiting

Study contacts

  • Principal investigator: Robert Zachariae, Professsor, DMSc, MSc — University of Aarhus and Aarhus University Hospital
  • Study coordinator: Morten J Lopdrup, MSc
  • Email: mlop@psy.au.dk
  • Phone: +45 87 16 90 52

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • APSTZD for Insomnia: Safety and Effectiveness in Adults

    This trial tests APSTZD against an active drug and placebo to see if it helps adults with insomnia.

    Recruiting Phase 2 Apsen Farmaceutica S.A. · Bragança Paulista, São Paulo · NCT07420816

  • Culturally adapted sleep education for older Korean immigrants

    This pilot tests a Korean-language, culturally adapted CBT-I sleep education program to see if it improves sleep for older Korean immigrants with chronic insomnia.

    Recruiting University of California, Los Angeles · Los Angeles, California · NCT07387406

  • Remote CBT-I with IoT and AI for Insomnia in Older Adults

    This trial tests if a fully remote, AI‑driven digital CBT‑I program with IoT environmental cues helps older adults with insomnia more than two active CBT‑I–based or sleep hygiene controls.

    Recruiting at 2 sites Phase 2 Proactive Life Inc · New York, New York and 1 other locations · NCT07316153

  • Trazodone for insomnia in adults 65 and older

    This trial will test whether taking low-dose trazodone at bedtime helps reduce insomnia symptoms in adults aged 65 and older compared with a placebo.

    Recruiting Phase 2 Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT06983080

  • Bedtime mindfulness meditation for chronic trouble falling asleep

    This pilot will test whether a 4-week bedtime mindfulness app helps adults with chronic trouble falling asleep compared with an unguided meditation app or sleep hygiene education.

    Recruiting Phase 1/2 Brigham and Women's Hospital · Boston, Massachusetts · NCT06972303

  • Ba Duan Jin exercise for chronic insomnia with anxiety

    This study is testing whether practicing Ba Duan Jin, a traditional Chinese exercise, can help people with chronic insomnia and anxiety sleep better and feel less anxious compared to just getting sleep education.

    Recruiting Xuanwu Hospital, Beijing · Beijing · NCT06969079

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.